Tesamorelin 10mg
Lyophilised powder · GHRH analogue · Vial
We don’t sell a compound until our own independent third-party testing is complete. This one is in verification — leave your email and we’ll tell you the moment its certificate of analysis is published.
Store at 2–8°C. Protect from light and moisture.
Independent Certificate of Analysis in progress — published once our own testing is complete.
About This Product
Tesamorelin is a synthetic growth hormone-releasing factor (GHRH) analogue first approved by the FDA in 2010 for HIV-associated lipodystrophy — the only GHRH analogue ever approved by the FDA. Research has since explored its effects on adipose tissue distribution and lipid metabolism.
Works through the body’s own GHRH receptors to stimulate natural, pulsatile GH release. 10mg per vial.
Read the Tesamorelin research guide→